Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

NCT01158144 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Endostar
DRUG: Paclitaxel/Carboplatin

Sponsor

Zhejiang Cancer Hospital